J
John W. Eikelboom
Researcher at Boehringer Ingelheim
Publications - 1
Citations - 780
John W. Eikelboom is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Idarucizumab & Andexanet alfa. The author has an hindex of 1, co-authored 1 publications receiving 626 citations.
Papers
More filters
Journal ArticleDOI
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Charles V. Pollack,Paul A. Reilly,Joanne van Ryn,John W. Eikelboom,Stephan Glund,Richard A. Bernstein,Robert Dubiel,Menno V. Huisman,Elaine M. Hylek,Elaine M. Hylek,Chak-Wah Kam,Chak-Wah Kam,Pieter Willem Kamphuisen,Jörg Kreuzer,Jerrold H. Levy,Gordon A. Royle,Frank W. Sellke,Joachim Stangier,Thorsten Steiner,Thorsten Steiner,Peter Verhamme,Bushi Wang,Laura Young,Jeffrey I. Weitz +23 more
TL;DR: In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran.